ALMR Consumables — Revenue increased by 177.9% to $13.96M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing adoption and utilization of the company's platform by researchers and clinical users, suggesting a healthy installed base. A decrease may signal reduced experimental activity, competition from alternative technologies, or a decline in the number of active platform users.
This metric represents the total revenue generated from the sale of consumable products used in conjunction with the com...
Comparable to 'Consumables Revenue' or 'Recurring Reagent Revenue' reported by life sciences and diagnostics companies that utilize a razor-and-blade business model.
almr_segment_consumables_revenue_from_contract_with_customer_excluding_assessed_tax| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $5.02M | $13.96M |
| QoQ Change | — | +177.9% |
| YoY Change | — | +177.9% |